Skip to main content
Metagenomi, Inc. logo

Metagenomi, Inc. — Investor Relations & Filings

Ticker · MGX ISIN · US59102M1045 US Professional, scientific and technical activities
Open in API
Filings indexed 124 across all filing types
Latest filing 2024-02-05 Board/Management Inform…
Country US United States of America
Listing US MGX

About Metagenomi, Inc.

https://metagenomi.co/

Metagenomi, Inc. is a genetic medicines company that develops curative therapeutics using its proprietary genome editing toolbox. The company's approach is founded on metagenomics, the study of genetic material recovered from natural environments, to discover and engineer novel gene editing systems. Its wholly-owned toolbox is designed to be capable of correcting various types of genetic mutations through site-specific deletion, integration, and correction. Metagenomi leverages high-throughput screening and AI-based cloud computing to expand its portfolio of editing technologies, focusing on disease indications with well-understood biology and clear clinical development pathways.

Recent filings

Filing Released Lang Actions
Board/Management Information 2024
Board/Management Information Classification · 100% confidence The document is a resignation letter from a board member, Risa Stack, indicating her automatic resignation from the board contingent upon the effectiveness of the company's registration statement on Form S-1. The content focuses on a change in the company's board of directors and does not contain financial data, audit information, or other report types. It is clearly an announcement of a board/management change. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a regulatory filing of a different nature.
2024-02-05 English
S-1/A
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A Registration Statement Amendment No. 2 filed with the SEC for Metagenomi, Inc. It is a preliminary prospectus related to an initial public offering (IPO) of common stock. The document includes detailed information about the offering, company overview, risk factors, financial data, management discussion, and other disclosures typical of an IPO registration statement. This type of filing is a capital markets document related to fundraising and securities registration, not a financial report like an annual or quarterly report. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2024-02-05 English
Board/Management Information 2024
Board/Management Information Classification · 100% confidence The document is a resignation letter of a board member, Santhosh Palani, from the Board of Managers of Metagenomi Technologies, LLC. It includes formal notification to the SEC and references to the company's registration statement. There is no financial data, earnings information, or report content. The primary content is about a change in the company's board of directors. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS.
2024-01-19 English
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The document is a letter from legal counsel to the SEC regarding a confidential treatment request related to an Amendment No. 1 to a Registration Statement on Form S-1 for Metagenomi Technologies, LLC. It discusses valuation methods for stock-based compensation and preliminary IPO price ranges. The document is a regulatory correspondence related to an IPO registration statement amendment, not a financial report, earnings release, or other specific report type. It is primarily a regulatory filing addressing SEC comments and confidential treatment requests. The document length is substantial but it is a letter, not a full report. Therefore, it fits best under Regulatory Filings (RNS).
2024-01-16 English
S-1/A
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 1 to a Form S-1 Registration Statement filed with the SEC for Metagenomi, Inc. It is a preliminary prospectus related to an initial public offering (IPO) of common stock. The Form S-1 is a registration statement used by companies planning to go public to register their securities with the SEC. The document includes detailed information about the offering, company overview, risk factors, management, financial data, and other disclosures typical of an IPO prospectus. This is not an annual report, earnings release, or any other type of financial report but a registration statement for securities offering. Therefore, the correct classification is Regulatory Filings (RNS), as it is a regulatory filing that does not fit into other specific categories like 10-K or ER.
2024-01-08 English
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The document is a letter from a company's legal counsel responding to comments from the SEC staff regarding a Draft Registration Statement on Form S-1. It references amendments to the Draft Registration Statement and discusses the use of proceeds from an offering. The document is a correspondence related to the registration process for a securities offering, specifically a Form S-1, which is used for initial public offerings or other securities registrations. It is not the registration statement itself, nor a financial report or earnings release. It is also not a proxy, voting result, or management change announcement. The letter is a regulatory communication responding to SEC comments, which fits best under Regulatory Filings (RNS), as it is a miscellaneous regulatory submission that does not fit other categories. The document length is short (3334 characters), and it is a letter rather than a report or presentation. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-01-05 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.